ALPHARETTA, Ga. - eTradeWire -- Fusion Health and Vitality LLC is voluntarily recalling all 2020 Lots of CORE essential nutrients and Immune Boost Sublingual Vitamin D3. CORE has been found to found to contain an unapproved food additive, hordenine HCl, rendering it adulterated. Immune Boost Labeling was found to contain statements that caused it to become and unapproved new drug under FDA labeling laws. Hordenine HCl is possibly unsafe when taken by mouth. Hordenine HCl might have similar stimulant effects and side effects such as rapid heart rate and high blood pressure.

Fusion Health and Vitality LLC has not received any reports of adverse events related to this recall.  Please review the attached photos for identification.

More on eTradeWire News

• HomeLight Honors THE MADRONA GROUP in 2020 Achievements™Awards, Top Performing Agents in the US
• Fred Haas Toyota World Dealership Launches Truck Month January 25, 2021 near Houston
• Brazil's ANVISA Grants Novel Food Approval for NEM® brand eggshell membrane
• Candidate proclaims that healing America should begin in Louisiana's 5th Congressional District
• Chicks With Cheques Announces Free New Year, New CEO Virtual Summit

We began shipping Core Essential Nutrients on 1/2/2020 and we began shipping Immune Boost Sublingual Vitamin D3 on 4/15/2020.

Both products are packaged with labels which prominently display the product name. CORE essential nutrients are found in a dark colored jar, in powdered format.  This product was formulated to mix into a liquid before consumption.

The Immune Boost sublingual was packaged in a 2 ounce bottle that came with a sublingual application dropper.

Fusion Health and Vitality is notifying its customers by email and is arranging for return of all recalled products.

Consumers that have product which is being recalled should stop using it and return it to Fusion Health and Vitality for destruction.

Consumers with questions regarding this recall or how to return recalled product can contact Fusion Health and Vitality by calling 1-888-964-5327, 9am to 5pm, Monday Thru Friday, EST.

More on eTradeWire News

• Bge Digital Distribution Acknowledges Artists For Musical Achievements
• CreditSnap, a next generation FinTech startup, announces strategic seed investment from multi-lender finance platform Tresl, its earliest adopter
• Very Important Relationships Inc. Announces Program to Help Bloggers Podcast Hosts, and Influences G
• Automation Intellect Announces Launch of ChangeoverIQ, the First Digital SMED Solution for Manufacturers
• Unhacking Password Attacks with Roger Grimes

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

Complete and submit the report Online: www.fda.gov/medwatch/report.htm

Regular Mail or Fax: Download form www.fda.gov/MedWatch/getforms.htm  or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.